Membrane vesicles in ovarian cancer fluids: A new potential marker

Anticancer Research

Volumn 19, Issue 4 C, 1999, Pages 3439-3445

  Ginestra, Angela ^a   Miceli, Donatella ^a   Dolo, Vincenza ^a   Romano, Franco Maria ^b   Vittorelli, Maria Letizia ^a,c  

^a UNIVERSITY OF PALERMO   (Italy)

^b Ospedale Oncologico M Ascoli   (Italy)

^c Centro di Oncobiologia Sperimentale   (Italy)

Author keywords

Matrix metalloproteinases; Ovarian cancer; Shed vesicles; Tumor progression

Indexed keywords

CA 125 ANTIGEN; GELATIN; GELATINASE A; GELATINASE B; TUMOR MARKER;

ADULT; AGED; ARTICLE; ASCITES FLUID; BODY FLUID; CANCER CELL; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MEMBRANE VESICLE; OVARY CANCER; PRIORITY JOURNAL; ZYMOGRAPHY;

ASCITIC FLUID; BODY FLUIDS; CA-125 ANTIGEN; CELL MEMBRANE; DENSITOMETRY; DISEASE PROGRESSION; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, ELECTRON; OVARIAN NEOPLASMS; PROGNOSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033458876     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. MacDonald ND, Rosenthal AN and Jacobs IJ: Screening for ovarian cancer. Ann Acad Med Singapore 27: 676-682, 1992.
2. Barnhill D, O'Connor D, Farley J, Tenerillo M, Armstrong D and Park R: Clinical surveillance of gynecologic patients. Gynecol Oncol 4: 275-280, 1992.
3. Dainiak N: Surface membrane-associated regulation of cell assembly, differentiation and growth: Blood 78: 264-276, 1991.
4. Taylor DD and Black PH: Shedding of plasma membrane fragments. Neoplastic and developmenta} importance. In: Developmental Biology 3 (Steinberg M, ed).New York, Plenum Press, 1986, pp33-57.
5. Taylor D D and Black PH: Inhibition of macrophages la antigen expression by shed plasma membrane vesicles from metastatic murine melanoma lines. J Natl Cancer Inst 74: 859-867, 1985.
6. 3H-thymidine incorporation are neutralised by anti TGF-β antibodies. J Submier Cytol Pathol J 27: 535-541, 1995.
7. Albanese J, Meterissian S, Kontogiannea M, Dubreuil C, Hand A, Sorba S and Dainiak N: Biologically active Fas antigen and its cognate ligand are expressed on plasma membrane-derived extracellular vesicles. Blood 91: 3862-3874, 1998.
8. Poste G and Nicolson GL: Arrest and metastasis of blood-born tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells. Proc Natl Acad Sci U.S.A. 77: 399-403, 1980.
9. Dolo V, Ginestra A, Ghersi G, Nagase H and Vittorelli ML: Human breast carcinoma cells cultured in the presence of serum shed membrane vesicles rich in gelatinolytic activities. J Submier Cytol Pathol 26: 173-180, 1994.
10. Ginestra A, Monea S, Seghezzi G, Dolo V, Nagase H, Mignatti P and Vittorelli ML: Gelatinases and urokinase type plasminogen activator are associated with membrane vesicles shed by HT1080 human fibrosarcoma cells. J Biol Chem 272: 17216-17222, 1997.
11. Dolo V, D'Ascenzo S, Pompucci L, Violini S, Festuccia C, Ginestra A, Vittorelli ML, Canevari S and Pavan A: Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer in vivo and in vitro. Clin Exp Metast 17: 131-140, 1999.
12. Van Blitterswijk WJ, De Veer G, Krol JH and Emmelot P: Comparative lipid analysis of purified plasma membranes and shed extracellular membrane vesicles from normal murine thymocytes and leukaemia GRSL cells. Bioch Bioph Acta 688: 496-504, 1982.
13. Dolo V, Ginestra A, Cassara D, Violini S, Lucania G, Torrisi M, Nagase H, Canevari S, Pavan A, and Vittorelli ML: Selective localization of MMP-9, β-1 integrins and HLA-I molecules on membrane vesicles shed by 8701-BC breast carcinoma cells. Cancer Res 58: 4468-4474, 1998.
14. Nagase H, Barrett AJ and Woessner JF jr: Nomenclature and glossary of the matrix metalloproteinases. Matrix suppl 1: 421-424, 1992 .
15. Woessner JF jr: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5: 2145-2154, 1991.
16. Mignatti P and Rifkin DB: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161-195, 1993.
17. Nagase H: In: Metalloproteases in Health and Disease (Hooper NM, ed). London, Taylor and Francis Ltd., 1996, pp153-204.
18. Taylor DD, Chou IN and PH Black: Isolation of plasma membrane fragments from cultured murine melanoma cells. Biochem Biophys Res Commun 113: 470-476, 1983.
19. Ginestra A, La Placa M D, Saladino F, Cassara D, Nagase H and Vittorelli ML: Amount and proteolytic content of vesicles shed by cancer cell lines correlate with their in vitro invasiveness. Anticancer Res 18: 3433-3438, 1998.
20. Tarin D: Fine structure of murine mammmary tumors: the relationship between epithelium and connective tissue in neoplasm induced by various agents. Br J Cancer 23: 417-425, 1969.
21. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
22. Fishman DA, Bafetti LM, Banionis S, Kearns AS, Chilukuri K, and Stack MS. Production of extracellular matrix-degrading proteinases by primary cultures by human epithelial ovarian carcinoma cells. Cancer 80: 1457-1463, 1997.
23. Rustin GJ, Nelstrop AE, McClean P, Brady MF, McGuire WP, Horkins WJ, Mitchell H and Lambert HE: Defining response of ovarian carcinoma to initial chemotheraphy according to serum Ca 125. J Clin Oncol 14: 1545-1551, 1996.